Silexion Therapeutics And Moringa Acquisition Corp Announce Closing Of Business Combination; Expected To Begin Trading On Nasdaq Under The Ticker "SLXN" On August 16, 2024
Portfolio Pulse from Benzinga Newsdesk
Silexion Therapeutics Ltd. and Moringa Acquisition Corp have completed their business combination, forming Silexion Therapeutics Corp. The new entity will start trading on Nasdaq under the ticker 'SLXN' on August 16, 2024.
August 15, 2024 | 8:09 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Moringa Acquisition Corp has completed its business combination with Silexion Therapeutics Ltd., forming Silexion Therapeutics Corp. The new entity will trade on Nasdaq under the ticker 'SLXN' starting August 16, 2024.
The completion of the business combination and the upcoming trading under a new ticker is a significant milestone for Moringa Acquisition Corp. This event is likely to positively impact the stock price in the short term as it transitions to a new, potentially more valuable entity.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 80